The global Antibiotic Susceptibility Testing market is projected to grow from USD 4.5 billion in 2023 to USD 7.9 billion by 2030, with a compound annual growth rate (CAGR) of 8.4% during the forecast period. The increasing demand for accurate diagnostics, the rapid spread of antimicrobial resistance (AMR), and the ongoing development of advanced diagnostic technologies are all contributing to the growth of this market.